Display Settings:

Format

Send to:

Choose Destination
    Science. 2006 Jun 9;312(5779):1530-3.

    Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.

    Source

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. nletvin@bidmc.harvard.edu

    Abstract

    Vaccine-induced cellular immunity controls virus replication in simian immunodeficiency virus (SIV)-infected monkeys only transiently, leading to the question of whether such vaccines for AIDS will be effective. We immunized monkeys with plasmid DNA and replication-defective adenoviral vectors encoding SIV proteins and then challenged them with pathogenic SIV. Although these monkeys demonstrated a reduction in viremia restricted to the early phase of SIV infection, they showed a prolonged survival. This survival was associated with preserved central memory CD4+ T lymphocytes and could be predicted by the magnitude of the vaccine-induced cellular immune response. These immune correlates of vaccine efficacy should guide the evaluation of AIDS vaccines in humans.

    PMID:
    16763152
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2365913
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Fig. 2
    Fig. 4
    Fig. 1
    Fig. 3

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk